Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

Similar articles for PubMed (Select 19774441)

1.

Fischer's score criteria correlating with histopathological prognostic factors in invasive breast cancer.

Girardi V, Carbognin G, Camera L, Tonegutti M, Bonetti F, Manfrin E, Pozzi Mucelli R.

Radiol Med. 2010 Apr;115(3):421-33. doi: 10.1007/s11547-009-0453-z. Epub 2009 Sep 22. English, Italian.

PMID:
19774441
2.
3.

Relationship between DCE-MRI morphological and functional features and histopathological characteristics of breast cancer.

Montemurro F, Martincich L, Sarotto I, Bertotto I, Ponzone R, Cellini L, Redana S, Sismondi P, Aglietta M, Regge D.

Eur Radiol. 2007 Jun;17(6):1490-7. Epub 2006 Dec 6.

PMID:
17149623
4.

Magnetic resonance imaging of breast cancer and correlation with prognostic factors.

Chang YW, Kwon KH, Choi DL, Lee DW, Lee MH, Lee HK, Yang SB, Kim Y, Seo DY.

Acta Radiol. 2009 Nov;50(9):990-8. doi: 10.3109/02841850903225180.

PMID:
19863408
5.

Rim enhancement of breast cancers on contrast-enhanced MR imaging: relationship with prognostic factors.

Jinguji M, Kajiya Y, Kamimura K, Nakajo M, Sagara Y, Takahama T, Ando M, Rai Y, Sagara Y, Ohi Y, Yoshida H.

Breast Cancer. 2006;13(1):64-73.

6.

Predictive value of the time-intensity curves on dynamic contrast-enhanced magnetic resonance imaging for lymphatic spreading in breast cancer.

Komatsu S, Lee CJ, Ichikawa D, Hamashima T, Morofuji N, Shirono K, Hosokawa Y, Okabe H, Kurioka H, Yamagishi H, Oka T.

Surg Today. 2005;35(9):720-4.

PMID:
16133665
7.

Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer.

Ueda S, Tsuda H, Asakawa H, Shigekawa T, Fukatsu K, Kondo N, Yamamoto M, Hama Y, Tamura K, Ishida J, Abe Y, Mochizuki H.

Jpn J Clin Oncol. 2008 Apr;38(4):250-8. doi: 10.1093/jjco/hyn019.

8.

Computer-aided interpretation of dynamic magnetic resonance imaging reflects histopathology of invasive breast cancer.

Baltzer PA, Vag T, Dietzel M, Beger S, Freiberg C, Gajda M, Camara O, Kaiser WA.

Eur Radiol. 2010 Jul;20(7):1563-71. doi: 10.1007/s00330-010-1722-x. Epub 2010 Mar 4.

PMID:
20204647
9.

Invasive breast cancer: correlation of dynamic MR features with prognostic factors.

Szabó BK, Aspelin P, Kristoffersen Wiberg M, Tot T, Boné B.

Eur Radiol. 2003 Nov;13(11):2425-35. Epub 2003 Jul 26.

PMID:
12898176
10.

Is there different correlation with prognostic factors between "non-mass" and "mass" type invasive ductal breast cancers?

Jiang L, Zhou Y, Wang Z, Lu X, Chen M, Zhou C.

Eur J Radiol. 2013 Sep;82(9):1404-9. doi: 10.1016/j.ejrad.2013.03.006. Epub 2013 Mar 27.

PMID:
23540946
11.

Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.

Hussein MR, Abd-Elwahed SR, Abdulwahed AR.

Cell Biol Int. 2008 Jun;32(6):698-707. doi: 10.1016/j.cellbi.2008.01.007. Epub 2008 Jan 25.

PMID:
18296077
12.

A new, preoperative, MRI-based scoring system for diagnosing malignant axillary lymph nodes in women evaluated for breast cancer.

He N, Xie C, Wei W, Pan C, Wang W, Lv N, Wu P.

Eur J Radiol. 2012 Oct;81(10):2602-12. doi: 10.1016/j.ejrad.2012.03.019. Epub 2012 Apr 21.

13.

Contrast-enhanced ultrasound in the characterisation of breast masses: utility of quantitative analysis in comparison with MRI.

Caproni N, Marchisio F, Pecchi A, Canossi B, Battista R, D'Alimonte P, Torricelli P.

Eur Radiol. 2010 Jun;20(6):1384-95. doi: 10.1007/s00330-009-1690-1. Epub 2009 Dec 22.

PMID:
20033178
14.

Diagnostic architectural and dynamic features at breast MR imaging: multicenter study.

Schnall MD, Blume J, Bluemke DA, DeAngelis GA, DeBruhl N, Harms S, Heywang-Köbrunner SH, Hylton N, Kuhl CK, Pisano ED, Causer P, Schnitt SJ, Thickman D, Stelling CB, Weatherall PT, Lehman C, Gatsonis CA.

Radiology. 2006 Jan;238(1):42-53.

PMID:
16373758
15.

Triple-negative invasive breast cancer on dynamic contrast-enhanced and diffusion-weighted MR imaging: comparison with other breast cancer subtypes.

Youk JH, Son EJ, Chung J, Kim JA, Kim EK.

Eur Radiol. 2012 Aug;22(8):1724-34. doi: 10.1007/s00330-012-2425-2. Epub 2012 Apr 17.

PMID:
22527371
16.

FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters.

Buck A, Schirrmeister H, Kühn T, Shen C, Kalker T, Kotzerke J, Dankerl A, Glatting G, Reske S, Mattfeldt T.

Eur J Nucl Med Mol Imaging. 2002 Oct;29(10):1317-23. Epub 2002 Jul 26.

PMID:
12271413
17.

Gadobenate dimeglumine as a contrast agent for dynamic breast magnetic resonance imaging: effect of higher initial enhancement thresholds on diagnostic performance.

Sardanelli F, Fausto A, Esseridou A, Di Leo G, Kirchin MA.

Invest Radiol. 2008 Apr;43(4):236-42. doi: 10.1097/RLI.0b013e318160678d.

PMID:
18340247
18.
19.

Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.

Yabuuchi H, Matsuo Y, Okafuji T, Kamitani T, Soeda H, Setoguchi T, Sakai S, Hatakenaka M, Kubo M, Sadanaga N, Yamamoto H, Honda H.

J Magn Reson Imaging. 2008 Nov;28(5):1157-65. doi: 10.1002/jmri.21570.

PMID:
18972357
20.

Male breast carcinoma: correlation of ER, PR, Ki-67, Her2-Neu, and p53 with treatment and survival, a study of 65 cases.

Wang-Rodriguez J, Cross K, Gallagher S, Djahanban M, Armstrong JM, Wiedner N, Shapiro DH.

Mod Pathol. 2002 Aug;15(8):853-61.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk